Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. relates to the company's Annual General Meeting of Shareholders originally scheduled for September 8, 2022. The filing serves to notify shareholders and the market that the meeting was adjourned due to a lack of quorum.
Key Event Details
- Original Date: September 8, 2022
- Reason for Adjournment: Lack of quorum
- Reconvened Date: September 15, 2022
- Time: 3:00 p.m. (Israel time)
- Location: 13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates are reported in this filing. The only material change noted is the rescheduling of the Annual General Meeting.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It does not disclose new risks, contingencies, or unusual items beyond the procedural delay of the shareholder meeting.
Investor Verification Checklist
- Verify the outcome of the reconvened Annual General Meeting on September 15, 2022.
- Review the company's most recent Form 20-F or quarterly reports for actual financial performance data, as this 6-K does not include it.
- Confirm the quorum requirements and attendance levels for the rescheduled meeting.